Healing & Recovery

BPC-157 & TB-500 & GHK-Cu Blend

A three-component healing research blend combining BPC-157 and TB-500 for systemic repair with GHK-Cu for collagen matrix stimulation and copper-mediated angiogenesis.

C62H98N16O22 / C28H43N7O10 / C14H22CuN4O4Half-life: Varies by component

⚠ Research & Educational Use Only. BPC-157 & TB-500 & GHK-Cu Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.

Medically reviewed by Dr. Amanda Reid, MDWritten by the KnowYourPeptide Research TeamLast updated April 2026
Our editorial standards →
Key Takeaways
  • Triple-mechanism healing protocol
  • BPC-157 + TB-500 systemic repair + GHK-Cu collagen matrix stimulation
  • Copper tripeptide adds angiogenic and fibroblast stimulation
  • BPC-157 & TB-500 & GHK-Cu Blend is not FDA-approved for human use. It is a research chemical for scientific study only.

Research At a Glance

  • Triple-mechanism healing protocol
  • BPC-157 + TB-500 systemic repair + GHK-Cu collagen matrix stimulation
  • Copper tripeptide adds angiogenic and fibroblast stimulation
  • Targeted for comprehensive musculoskeletal and skin recovery research

What is BPC-157 & TB-500 & GHK-Cu Blend?

The BPC-157 & TB-500 & GHK-Cu Blend adds GHK-Cu (Copper Tripeptide-1) to the established BPC-157 + TB-500 healing combination. GHK-Cu contributes complementary collagen matrix-stimulating activity and copper-mediated angiogenesis that supports the repair environment created by BPC-157 and TB-500.

What It Is

  • BPC-157: systemic healing peptide via NO pathway, VEGF, GH receptor upregulation
  • TB-500: actin dynamics and VEGF-mediated cell migration; cardiac and neural repair
  • GHK-Cu: copper-chelating tripeptide that upregulates collagen I, III, and IV; promotes TGF-beta-mediated fibroblast synthesis; antioxidant and anti-inflammatory
  • Three complementary healing mechanisms in a single research preparation

How It Works

  • BPC-157 + TB-500: angiogenesis and cell migration to the repair site
  • GHK-Cu: ensures the extracellular matrix framework is being laid down by stimulated fibroblasts
  • Copper component of GHK-Cu activates lysyl oxidase (cross-links collagen for mechanical strength) and SOD (antioxidant protection)
  • Triple mechanism addresses vascularization, cellular repair, and matrix reconstruction simultaneously

Key Research Findings

  • No published head-to-head triple combination vs individual components
  • Component-level data: each peptide independently accelerates healing in respective tissue models
  • GHK-Cu addition specifically relevant in skin and connective tissue research where collagen matrix quality is the endpoint

Dosing From the Literature

  • BPC-157: 250-500 mcg subcutaneous
  • TB-500: 2-5 mg subcutaneous
  • GHK-Cu: 1-2 mg subcutaneous or topical application
  • 2-3 times per week

Storage and Handling

  • Lyophilised: 2-8 degrees C; 24 months
  • Reconstituted: 2-8 degrees C; use within 28 days
  • GHK-Cu stable in aqueous solution at pH 6-7.5; avoid strong acidic conditions

Key Research Benefits

Documented effects observed in preclinical and clinical studies on BPC-157 & TB-500 & GHK-Cu Blend. See all Healing & Recovery peptides for comparison.

Triple-mechanism healing protocol
BPC-157 + TB-500 systemic repair + GHK-Cu collagen matrix stimulation
Copper tripeptide adds angiogenic and fibroblast stimulation
Targeted for comprehensive musculoskeletal and skin recovery research

Side Effects & Risks

Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports.

Individual component side effects apply
GHK-Cu adds topical/local copper signaling
Generally well tolerated in preclinical research

Dosing Data from the Literature

Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.

Research Dosing Protocol

BPC-157 250-500 mcg + TB-500 2-5 mg + GHK-Cu 1-2 mg per administration. 2-3 times per week.

Enter your vial size and target dose to get the exact injection volume.

Administration in Research Settings

Standard reconstitution and administration methodology for laboratory research use.

Subcutaneous or intramuscular injection. GHK-Cu may also be applied topically to skin lesions.

Explore Further

Quick Reference

Half-Life
Varies by component
Formula
C62H98N16O22 / C28H43N7O10 / C14H22CuN4O4
Legal Status
Research chemicals. Not approved for human use.
Storage
Lyophilised components: 2-8 degrees C. Reconstituted: 2-8 degrees C; use within 28 days.

Research Use Only

This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.